Asosiy Perp DEX-lar sharhi: Dam olish kunlari barcha platformalarda savdo hajmi pasaydi, Hyperliquid ochiq shartnomalar hajmi o‘tgan haftaga nisbatan 10% ga oshdi
BlockBeats xabariga ko‘ra, 4-yanvar kuni DefiLlama ma’lumotlariga asoslanib, dam olish kunlari Perp DEX savdo hajmi sust bo‘ldi, Hyperliquid taxminan 3 milliard dollar savdo hajmi bilan yetakchilik qildi, uning ochiq shartnomalari hajmi o‘tgan haftaga nisbatan taxminan 10% ga oshdi; Variational va Paradex savdo hajmi esa doimiy ravishda oshib bormoqda va hozirda mos ravishda to‘rtinchi va beshinchi o‘rinda turibdi. Hozirgi vaqtda ayrim Perp DEX savdo hajmlari quyidagicha:
Hyperliquid 24 soatlik savdo hajmi taxminan 3.09 milliard dollar, TVL taxminan 4.18 milliard dollar, ochiq shartnomalar hajmi 7.77 milliard dollar;
Lighter 24 soatlik savdo hajmi taxminan 2.87 milliard dollar, TVL taxminan 1.27 milliard dollar, ochiq shartnomalar hajmi 1.4 milliard dollar;
Aster 24 soatlik savdo hajmi taxminan 2.5 milliard dollar, TVL taxminan 1.24 milliard dollar, ochiq shartnomalar hajmi 2.6 milliard dollar;
Variational 24 soatlik savdo hajmi taxminan 1.53 milliard dollar, TVL taxminan 66.18 million dollar, ochiq shartnomalar hajmi 779 million dollar;
Paradex 24 soatlik savdo hajmi taxminan 1.47 milliard dollar, TVL taxminan 170 million dollar, ochiq shartnomalar hajmi 799 million dollar;
EdgeX 24 soatlik savdo hajmi taxminan 1.39 milliard dollar, TVL taxminan 359 million dollar, ochiq shartnomalar hajmi 803 million dollar;
Pacifica 24 soatlik savdo hajmi taxminan 668 million dollar, TVL taxminan 42.89 million dollar, ochiq shartnomalar hajmi 73.88 million dollar.
Mas'uliyatni rad etish: Ushbu maqolaning mazmuni faqat muallifning fikrini aks ettiradi va platformani hech qanday sifatda ifodalamaydi. Ushbu maqola investitsiya qarorlarini qabul qilish uchun ma'lumotnoma sifatida xizmat qilish uchun mo'ljallanmagan.
Sizga ham yoqishi mumkin
Novartis (NVS.US) neyroimmun tizim bo‘yicha tadqiqotlarda “yaxshi va yomon xabarlar”: CAR-T klinik sinovi bemor vafoti sabab to‘xtatildi, MS uchun og‘iz orqali qabul qilinadigan dori sinovlari esa muvaffaqiyatli yakunlandi
Novartis (NVS.US) asab va autoimmun sohalarida "ikki xil holat"ni boshdan kechirmoqda.



KKR’ga qarashli go'zallik brendi kompaniyasi Wella Company (WELA.US) AQShda IPO uchun ariza berdi, 500 million AQSh dollaridan ortiq mablag‘ jalb qilishni rejalashtirmoqda.
AQSh Securities and Exchange Commission (SEC) tomonidan e'lon qilingan hujjatlarga ko‘ra, KKRga tegishli kosmetika brendlariga egalik qiluvchi Wella Company (WELA.US) joriy hafta dushanba kuni rasman IPO uchun ariza taqdim etdi. Bozor prognozlariga ko‘ra, to‘plangan mablag‘ hajmi 500 million dollardan oshishi kutilmoqda.
